Glutamate-cysteine ligase catalytic subunit is associated with cisplatin resistance in lung adenocarcinoma

BACKGROUND: Cisplatin is a key drug for treating lung adenocarcinoma, and its sensitivity to cisplatin is directly related to prognosis. We aimed to reveal the roles of genes related to glutathione synthesis (glutamate-cysteine ligase catalytic subunit, GCLC) and cystine uptake (cystine/glutamate tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiyama, Noriko, Ando, Takahiro, Maemura, Keita, Sakatani, Toshio, Amano, Yosuke, Watanabe, Kousuke, Kage, Hidenori, Yatomi, Yutaka, Nagase, Takahide, Nakajima, Jun, Takai, Daiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892860/
https://www.ncbi.nlm.nih.gov/pubmed/29474642
http://dx.doi.org/10.1093/jjco/hyy013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892860/
https://www.ncbi.nlm.nih.gov/pubmed/29474642
http://dx.doi.org/10.1093/jjco/hyy013

Ejemplares similares